stars 1 stars 2 stars 3

Established in 2014, 4P-Pharma is a clinical-stage biotech company dedicated to addressing serious diseases with significant unmet medical needs. Our goal is to bring first-in-class therapies to patients swiftly. Our core is a specialized R&D engine that enhances risk management and accelerates the development process, effectively cutting down on time, costs, and uncertainty. We focus on developing assets combining rapid time to market and solid intellectual property. Our strategy leverages cutting-edge clinical trial designs and expedited regulatory pathways to bring our therapies to those in need as quickly as possible.

4P-Pharma Questions

The 4P-Pharma annual revenue was $14.9 million in 2026.

Revital Rattenbach is the CEO of 4P-Pharma.

22 people are employed at 4P-Pharma.

4P-Pharma is based in Lille, Wallis and Futuna.

The NAICS codes for 4P-Pharma are [33, 32, 325, 3254].

The SIC codes for 4P-Pharma are [2834, 283, 28].

Top 4P-Pharma Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users